
Sign up to save your podcasts
Or


A class of drugs typically prescribed for obesity and diabetes is shrinking the bodies of those who can afford it. Jia Tolentino, staff writer at The New Yorker, and author of Trick Mirror: Reflections on Self-Delusion (Random House, 2019), discusses her latest piece on the rise of Ozempic, and how it may change our perception of fatness.
By WNYC4.6
15141,514 ratings
A class of drugs typically prescribed for obesity and diabetes is shrinking the bodies of those who can afford it. Jia Tolentino, staff writer at The New Yorker, and author of Trick Mirror: Reflections on Self-Delusion (Random House, 2019), discusses her latest piece on the rise of Ozempic, and how it may change our perception of fatness.

38,609 Listeners

6,780 Listeners

3,959 Listeners

9,254 Listeners

8,461 Listeners

4,086 Listeners

483 Listeners

12,714 Listeners

14,452 Listeners

6,473 Listeners

1,543 Listeners

3,505 Listeners

113,344 Listeners

2,801 Listeners

1,405 Listeners

2,380 Listeners

1,196 Listeners

5,573 Listeners

5,767 Listeners

421 Listeners

7,282 Listeners

674 Listeners

16,421 Listeners

2,823 Listeners

645 Listeners

262 Listeners

1,970 Listeners

1,606 Listeners

83 Listeners

659 Listeners

631 Listeners

258 Listeners

20 Listeners